Clinical Trial Update: Decitabine and Cedazuridine in Combination With Venetoclax for the Treatment of Patients Who Have Relapsed Acute Myeloid Leukemia After Donor Stem Cell Transplant [Phase 2]

View source ↗

Summary

A Phase 2 trial of decitabine/cedazuridine with venetoclax for relapsed acute myeloid leukemia after donor stem cell transplant was terminated, with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Cedazuridine (Cedazuridine)
• Dacogen (decitabine)
• Venclexta (venetoclax)

Snippet

Sponsor: Sanjay Mohan | Conditions: Recurrent Acute Myeloid Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2026-01-09